Nicolas Penel

Also affiliated with Centre Hospitalier Universitaire de Lille, Lille’s Cardiology Hospital, The Lymphoma Academic Research Organisation, Centre Oscar Lambret, Institut Bergonié, Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study”.

Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study

European Journal of Cancer(2021)10.1016/j.ejca.2021.03.039

N/A

1.3DataRank · unranked

47 citations

Antoîne Italiano, Emannuelle Bompas, María Rios, Nicolas Penel, Olivier Mir +18 more